152 related articles for article (PubMed ID: 35344967)
1. Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications.
Persson K; Edwin TH; Knapskog AB; Tangen GG; Selbæk G; Engedal K
Dement Geriatr Cogn Disord; 2022; 51(1):80-89. PubMed ID: 35344967
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
4. Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
Kannappan B; Te Nijenhuis J; Choi YY; Lee JJ; Choi KY; Balzekas I; Jung HY; Choe Y; Song MK; Chung JY; Ha JM; Choi SM; Kim H; Kim BC; Jo HJ; Lee KH
PLoS One; 2022; 17(11):e0275233. PubMed ID: 36327265
[TBL] [Abstract][Full Text] [Related]
5. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
[TBL] [Abstract][Full Text] [Related]
6. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
Liu G; Liu C; Qiu A;
Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.
Kothapalli SVVN; Benzinger TL; Aschenbrenner AJ; Perrin RJ; Hildebolt CF; Goyal MS; Fagan AM; Raichle ME; Morris JC; Yablonskiy DA
J Alzheimers Dis; 2022; 85(2):905-924. PubMed ID: 34897083
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.
Dawe RJ; Bennett DA; Schneider JA; Arfanakis K
PLoS One; 2011; 6(10):e26286. PubMed ID: 22043314
[TBL] [Abstract][Full Text] [Related]
9. MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.
Persson K; Eldholm RS; Barca ML; Cavallin L; Ferreira D; Knapskog AB; Selbæk G; Brækhus A; Saltvedt I; Westman E; Engedal K
PLoS One; 2017; 12(10):e0186595. PubMed ID: 29036183
[TBL] [Abstract][Full Text] [Related]
10. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
11. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
[TBL] [Abstract][Full Text] [Related]
12. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
13. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
14. Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease.
Morais-Ribeiro R; Almeida FC; Coelho A; Oliveira TG;
Eur J Neurosci; 2024 Jun; 59(12):3376-3388. PubMed ID: 38654447
[TBL] [Abstract][Full Text] [Related]
15. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
[TBL] [Abstract][Full Text] [Related]
17. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
[TBL] [Abstract][Full Text] [Related]
18. Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
Xiao Y; Liao L; Huang K; Yao S; Gao L;
J Alzheimers Dis; 2023; 93(2):791-801. PubMed ID: 37092228
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging of hippocampal atrophy in early recognition of Alzheimer's disease--a critical appraisal after two decades of research.
Schröder J; Pantel J
Psychiatry Res Neuroimaging; 2016 Jan; 247():71-8. PubMed ID: 26774855
[TBL] [Abstract][Full Text] [Related]
20. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.
Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
